Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

5 Cannabis-Stock Technicals

Published 09/23/2019, 12:59 PM
Updated 07/09/2023, 06:32 AM

The Cannabis market is flourishing, especially in Europe. However, most of the major cannabis stocks seem to have been in an overvaluation hype bubble, which might have popped already. Thus, a trend switch might be around the corner and investors of cannabis stocks might see positive returns very soon again.

Daily Tilray

Tilray’s overall trend remains bearish as long as Tilray stays below the 50-day-EMA. Just recently, Tilray (NASDAQ:TLRY) reached almost the opening prices back in August 2018 which simultaneously formed a bullish divergence in the RSI. The divergence was quickly followed by a rise of 35 percent in the course of a single week. While the MACD still indicates bearishness, Tilray has still good chances to go for a re-test of the 50-day-EMA, which would lead to another 14 percent rise in price. Considering the very low levels Tilray has reached by now, it could be that the bearish trend comes to an end very soon and Tilray breaks the 50-day-EMA.

Weekly Canopy Growth

Canopy Growth (TSX:WEED) reached oversold regions in the RSI when it bounced off the golden ratio level at around $22. The golden ratio is a very important level and not seldom leads to an immense bounce towards the upside. For now, Canopy will most likely go for a re-test of the 0.382 fib level at $37, where the 50-day-EMA acts as additional resistance. While the MACD indicates bullishness and the RSI has reached the lowest point in 5 years, Canopy could even exceed the resistance at $45. However, the resistance at $30 could still deny the potential uptrend.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Weekly Cronos

Cronos Group (NASDAQ:CRON) is nearing oversold regions in the RSI and is close to the golden ratio at around $9.00 where it most likely bounce off strongly. Although the MACD is rather bullish, it seems likely that Cronos will continue its downtrend towards the $9.00 mark. Then, a long-entry could be very interesting for a decent price hike towards $12.00 to $16.00.

Weekly GW Pharmaceuticals

GW Pharmaceuticals (NASDAQ:GWPH) is currently at very interesting support levels. First and foremost, GWPH is at the 6-year-trendline support. Secondly, GWPH is at a very strong support level which formerly had been a resistance numerous times. While GWPH could possibly reach oversold RSI levels before a decent price correction towards the upside takes place, current price levels a worth considering a long-entry.

Weekly Aurora

Aurora Cannabis (TSX:ACB) is nearing the golden ratio as well, where it could bounce off heavily very soon. While the $5.00 price marks a very strong support level, it is also the lower trendline of the descending triangle, which acts as additional support. Although the overall trend is rather bearish, the RSI is very close to oversold regions which indicates an upcoming upward movement as well. Thus, the sub $5.00 levels could be a very interesting long-entry.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.